FR2714605A1 - Compsn. contg. colostrum, mimosa tenuiflora extract and rose water - Google Patents

Compsn. contg. colostrum, mimosa tenuiflora extract and rose water Download PDF

Info

Publication number
FR2714605A1
FR2714605A1 FR9400097A FR9400097A FR2714605A1 FR 2714605 A1 FR2714605 A1 FR 2714605A1 FR 9400097 A FR9400097 A FR 9400097A FR 9400097 A FR9400097 A FR 9400097A FR 2714605 A1 FR2714605 A1 FR 2714605A1
Authority
FR
France
Prior art keywords
colostrum
compsn
rose water
contg
extract
Prior art date
Legal status (The legal status is an assumption and is not a legal conclusion. Google has not performed a legal analysis and makes no representation as to the accuracy of the status listed.)
Pending
Application number
FR9400097A
Other languages
French (fr)
Inventor
Schlee Serge
Current Assignee (The listed assignees may be inaccurate. Google has not performed a legal analysis and makes no representation or warranty as to the accuracy of the list.)
Individual
Original Assignee
Individual
Priority date (The priority date is an assumption and is not a legal conclusion. Google has not performed a legal analysis and makes no representation as to the accuracy of the date listed.)
Filing date
Publication date
Application filed by Individual filed Critical Individual
Priority to FR9400097A priority Critical patent/FR2714605A1/en
Publication of FR2714605A1 publication Critical patent/FR2714605A1/en
Pending legal-status Critical Current

Links

Classifications

    • A—HUMAN NECESSITIES
    • A61—MEDICAL OR VETERINARY SCIENCE; HYGIENE
    • A61Q—SPECIFIC USE OF COSMETICS OR SIMILAR TOILETRY PREPARATIONS
    • A61Q19/00—Preparations for care of the skin
    • A—HUMAN NECESSITIES
    • A61—MEDICAL OR VETERINARY SCIENCE; HYGIENE
    • A61K—PREPARATIONS FOR MEDICAL, DENTAL OR TOILETRY PURPOSES
    • A61K36/00—Medicinal preparations of undetermined constitution containing material from algae, lichens, fungi or plants, or derivatives thereof, e.g. traditional herbal medicines
    • A61K36/18—Magnoliophyta (angiosperms)
    • A61K36/185—Magnoliopsida (dicotyledons)
    • A61K36/48—Fabaceae or Leguminosae (Pea or Legume family); Caesalpiniaceae; Mimosaceae; Papilionaceae
    • A—HUMAN NECESSITIES
    • A61—MEDICAL OR VETERINARY SCIENCE; HYGIENE
    • A61K—PREPARATIONS FOR MEDICAL, DENTAL OR TOILETRY PURPOSES
    • A61K36/00—Medicinal preparations of undetermined constitution containing material from algae, lichens, fungi or plants, or derivatives thereof, e.g. traditional herbal medicines
    • A61K36/18—Magnoliophyta (angiosperms)
    • A61K36/185—Magnoliopsida (dicotyledons)
    • A61K36/73—Rosaceae (Rose family), e.g. strawberry, chokeberry, blackberry, pear or firethorn
    • A61K36/738—Rosa (rose)
    • A—HUMAN NECESSITIES
    • A61—MEDICAL OR VETERINARY SCIENCE; HYGIENE
    • A61K—PREPARATIONS FOR MEDICAL, DENTAL OR TOILETRY PURPOSES
    • A61K8/00—Cosmetics or similar toiletry preparations
    • A61K8/18—Cosmetics or similar toiletry preparations characterised by the composition
    • A61K8/96—Cosmetics or similar toiletry preparations characterised by the composition containing materials, or derivatives thereof of undetermined constitution
    • A61K8/97—Cosmetics or similar toiletry preparations characterised by the composition containing materials, or derivatives thereof of undetermined constitution from algae, fungi, lichens or plants; from derivatives thereof
    • A61K8/9783—Angiosperms [Magnoliophyta]
    • A61K8/9789—Magnoliopsida [dicotyledons]
    • A—HUMAN NECESSITIES
    • A61—MEDICAL OR VETERINARY SCIENCE; HYGIENE
    • A61K—PREPARATIONS FOR MEDICAL, DENTAL OR TOILETRY PURPOSES
    • A61K8/00—Cosmetics or similar toiletry preparations
    • A61K8/18—Cosmetics or similar toiletry preparations characterised by the composition
    • A61K8/96—Cosmetics or similar toiletry preparations characterised by the composition containing materials, or derivatives thereof of undetermined constitution
    • A61K8/98—Cosmetics or similar toiletry preparations characterised by the composition containing materials, or derivatives thereof of undetermined constitution of animal origin
    • A61K8/981—Cosmetics or similar toiletry preparations characterised by the composition containing materials, or derivatives thereof of undetermined constitution of animal origin of mammals or bird
    • A61K8/986—Milk; Derivatives thereof, e.g. butter
    • A—HUMAN NECESSITIES
    • A61—MEDICAL OR VETERINARY SCIENCE; HYGIENE
    • A61Q—SPECIFIC USE OF COSMETICS OR SIMILAR TOILETRY PREPARATIONS
    • A61Q19/00—Preparations for care of the skin
    • A61Q19/08—Anti-ageing preparations

Abstract

Compsn. comprises: (1) colostrum, (2) extract of mimosa tenuiflora, (3) rose water, and (4) an excipient or a neutral support.

Description

La préserte invention concerne une structure composée formant urne combinaison de trois composants dont les principes actifs libérés, conjugés, intégrés dans un support à base d'excipient neutre donneront soit ur,e pommade ou onguent, crème, embrocation, emplâtre, liniment,topique. Cette formulation
Ou combinaison des ingrédients contenant les principes actifs associés à ladite couche de support formeront la structure terminale qui aura pour effet d'être polyactive et polyvalente, s'emploiera à lutter contre le vieillissement de la peau, les érythèmes, les brûlures peu étendues et favorisant la cicatrisation.The present invention relates to a composite structure forming a combination urn of three components whose active principles released, conjugated, integrated in a support based on neutral excipient will give either ur, e ointment or ointment, cream, embrocation, plaster, liniment, topical. This formulation
Or combination of the ingredients containing the active ingredients associated with said support layer will form the terminal structure which will have the effect of being polyactive and versatile, will work to fight against aging of the skin, erythema, small burns and promoting healing.

Les structures ou combinaisons classiques présentées sous forme de pommade, onguent, crème, embrocation, emplâtre, liniment, topique intégrant des principes actifs ont une action dirigée et un spectre limité à 1 'envir- rongement de l'application et de l'affection correspondantes pour lesquelles elles ont été conçues et fabriquées. Le traitement par ces structures se limite donc à un domaine bien précis de la thérapeutique.The classic structures or combinations presented in the form of an ointment, ointment, cream, embrocation, plaster, liniment, topical incorporating active ingredients have a directed action and a spectrum limited to the prolongation of the corresponding application and affection. for which they were designed and manufactured. Treatment with these structures is therefore limited to a very specific area of therapy.

L'investissement pour l'utilisateur est considérable du fait de l'achat de plusieurs produits en raison. de leurs spécificités. La gestion et la manipulation ne sont pas aisées.The investment for the user is considerable due to the purchase of several due products. of their specificities. Management and handling are not easy.

La présente invention a pour but de fournir une formule dont la structure associe plusieurs composants contenant des principes actifs qui intègrent une couche de support neutre.The object of the present invention is to provide a formula the structure of which combines several components containing active principles which integrate a neutral support layer.

L'ir.vention servira de façon à éviter dans une mesure substantielle les inconvenients mentionnés ci-dessus. The ir.vention will serve to avoid to a substantial extent the drawbacks mentioned above.

La présente et ses avantages apparaitront mieux dans la description de la formule.The present and its advantages will appear better in the description of the formula.

La structure de la formule composant l'invention est formée de - colostrum : qui est un liquide sécrété par les glandes mammaires, peu après l'accouchement, avant que s'installe la sécrétion lactée véritable.The structure of the formula making up the invention is made up of - colostrum: which is a liquid secreted by the mammary glands, shortly after childbirth, before the real milky secretion is established.

La préférence sera donnée au colostrum bovin étant cet fois plus a~tif que le colostrum humain. Ce colostrum sera notamment receuilli après le troisième velage aux première et deuxième traites sur des animaux sains, indemnes de résidus médicamentaux. Preference will be given to bovine colostrum being this time more a tif than human colostrum. This colostrum will be collected in particular after the third spinning in the first and second milking on healthy animals, free from medicinal residues.

Ce même colostrum sera concentré, pulvérisé tout en conservant l'intégralité des composants actifs et délipidé dont les résidus de matières grasses seront de moins de 1. This same colostrum will be concentrated, pulverized while retaining all the active components and defatted, the fat residues will be less than 1.

Le colostrum apportera comme composants actifs à ladite couche de support neutre les vitamines tels que : vitamine A pour la croissance des tissus, vitamines B1, B2, B12, B5, intervenant dans le métabolisme énergétique, dans les réactions d'oxydations cellulaires, sous forme de coenzyme A, dans le métabolisme lipidique.Colostrum will provide vitamins such as: vitamin A for tissue growth, vitamins B1, B2, B12, B5, active in energy metabolism, in cellular oxidative reactions, as active components to said neutral support layer. of coenzyme A, in lipid metabolism.

Des enzymes favorisant les échanges biologiques précurseurs de 1'A.D.N. Enzymes promoting biological exchanges that are precursors of A.D.N.

Des minéraux : calcium, phosphore, magnésium.Minerals: calcium, phosphorus, magnesium.

L'intégration de ce premier composant dans la couche de support a pour but de favoriser l'élaboration et la régénération des tissus.The integration of this first component in the support layer aims to promote the development and regeneration of tissues.

Le deuxième composants est : extrait d'écorce de Mimosa Tenuiflora, l'extr- ait ne devra plus contenir d'agents pathogènes, germes, micro-organismes, et de résidus chimiques dus aux produits phytosanitaires.The second component is: Mimosa Tenuiflora bark extract, the extract should no longer contain pathogens, germs, micro-organisms, and chemical residues due to phytosanitary products.

L'extrait de Mimosa Tenuiflora apporte comme principes actifs à ladite structure neutre de support : des flavonoides luttant c y RtiOr. ew des radicaux libres pour protèger le collagène, élément essentiel du tissu conjonctif de la peau.The extract of Mimosa Tenuiflora provides as active principles to said neutral support structure: flavonoids that fight against this and RtiOr. ew free radicals to protect collagen, an essential element in the connective tissue of the skin.

Le collagène étant protègé, cela stimulera la cicatrisation des tissus superficiels, luttera contre l'infection et la douleur.The collagen being protected, it will stimulate the healing of superficial tissues, will fight against infection and pain.

Le troisième composant est l'eau de rose : présentera ue exellente pureté les corolles utilisées seront exemptes de tous agents pathogè..es et de tous résidus chimiques n' intervenant pas dans la structure mère de la plante. L'intégration de ce troisième élément aura pour but de limiter le vieillissement précose et de fournir Üe senteur agréable.The third component is rose water: it will have excellent purity the corollas used will be free of all pathogens and all chemical residues which do not intervene in the mother structure of the plant. The integration of this third element will aim to limit premature aging and provide a pleasant scent.

Les composants contenant des substances actives pourront être introduits à des doses variées pour chacun d'entre eux dans la stucture de base ou de support neutre qui sera un excipient classique ou élaboré par un laboratoire. The components containing active substances can be introduced at various doses for each of them into the basic structure or neutral support which will be a conventional excipient or produced by a laboratory.

La présente formule pourra reçevoir selon la fabrication un antifongique.The present formula may receive, depending on the manufacture, an antifungal.

La formule peut être stérile ou non strérile selon le domaine d'application.The formula can be sterile or non-sterile depending on the area of application.

La présente invention peut-être intégrée dans un support tel qu'un paflsem- ent. The present invention can be integrated into a support such as a paflsem- ent.

La présente invention concer ne une formule (1) formant une structure composée intégrant du colostrum (2) de l'extrait de mimosa tenuiflora (3) de l'eau de rose (4) de l'excipient ou couche de support neutre (5). The present invention relates to a formula (1) forming a compound structure integrating colostrum (2) mimosa tenuiflora extract (3) rose water (4) excipient or neutral support layer (5 ).

Claims (1)

REVENDICATIONS.CLAIMS. Formule (1) formant une structure composée intégrant du colostrum (2) Formula (1) forming a compound structure incorporating colostrum (2) de l'extrait de mimosa tenulflora (3) de l'eau de rose (4) et l'excipient extract of mimosa tenulflora (3) rose water (4) and the excipient ou couche de support neutre (5). or neutral support layer (5). 2. Formule selon la revendication 1, caractérisé e ce que le colostrum 2. Formula according to claim 1, characterized in that the colostrum est receuilli après le troisième velage, pulvérisé et délipidé. is collected after the third spin, pulverized and defatted. Formule selon la revendication 1, caractérisé e ce que ladite formule Formula according to claim 1, characterized in that said formula se présentera sous formes de pommade, onguent, crème, embrocation, will be in the form of ointment, ointment, cream, embrocation, emplâtre, lInIment et topique.  plaster, InIment and topical.
FR9400097A 1994-01-05 1994-01-05 Compsn. contg. colostrum, mimosa tenuiflora extract and rose water Pending FR2714605A1 (en)

Priority Applications (1)

Application Number Priority Date Filing Date Title
FR9400097A FR2714605A1 (en) 1994-01-05 1994-01-05 Compsn. contg. colostrum, mimosa tenuiflora extract and rose water

Applications Claiming Priority (1)

Application Number Priority Date Filing Date Title
FR9400097A FR2714605A1 (en) 1994-01-05 1994-01-05 Compsn. contg. colostrum, mimosa tenuiflora extract and rose water

Publications (1)

Publication Number Publication Date
FR2714605A1 true FR2714605A1 (en) 1995-07-07

Family

ID=9458820

Family Applications (1)

Application Number Title Priority Date Filing Date
FR9400097A Pending FR2714605A1 (en) 1994-01-05 1994-01-05 Compsn. contg. colostrum, mimosa tenuiflora extract and rose water

Country Status (1)

Country Link
FR (1) FR2714605A1 (en)

Cited By (3)

* Cited by examiner, † Cited by third party
Publication number Priority date Publication date Assignee Title
WO2007009790A1 (en) * 2005-07-22 2007-01-25 Bionest Ltd. Cosmetic compositions containing hyaluronic acid and colostrum
FR2902335A1 (en) * 2006-06-16 2007-12-21 Nuxe Sa Lab Use of mimosa extract for the preparation of a cosmetic and/or dermatological composition for topical application, to fight against signs of skin aging
WO2007144518A3 (en) * 2006-06-16 2008-03-06 Nuxe Lab Use of a mimosa seed extract in a cosmetic composition

Cited By (3)

* Cited by examiner, † Cited by third party
Publication number Priority date Publication date Assignee Title
WO2007009790A1 (en) * 2005-07-22 2007-01-25 Bionest Ltd. Cosmetic compositions containing hyaluronic acid and colostrum
FR2902335A1 (en) * 2006-06-16 2007-12-21 Nuxe Sa Lab Use of mimosa extract for the preparation of a cosmetic and/or dermatological composition for topical application, to fight against signs of skin aging
WO2007144518A3 (en) * 2006-06-16 2008-03-06 Nuxe Lab Use of a mimosa seed extract in a cosmetic composition

Similar Documents

Publication Publication Date Title
JP7242718B2 (en) Formulations containing pomegranate seed oil, rosa canina fruit oil, and inula viscosa oleoresin or extract
EP0091368B1 (en) Compositions capable of fighting transpiration harm and inconveniences
EA002789B1 (en) Substance mixture for topical application
EA018425B1 (en) Pharmaceutical, disinfectant or preservation extract of trigonella foenum-graecum, method for preparing and use thereof
KR20110082292A (en) Antipuritis and antiance effects of dendropanax morbifera lev. extract
EP2364713B1 (en) Dermatological composition for use in the treatment of skin burns, skin diseases and infected wounds
KR101253374B1 (en) Cosmetic composition for controlling anti-acne and anti-comedo
US20040214750A1 (en) Medicaments for healing skin conditions in humans
JP3995720B2 (en) Cosmetic body care preparation and process for its production
FR2714605A1 (en) Compsn. contg. colostrum, mimosa tenuiflora extract and rose water
KR100418688B1 (en) The growth inhibition of Propionibacterium acnes for the multiple extracts of herbal medicaments
CN106318722A (en) Mite removal handmade soap
RU2405535C1 (en) Foot care cream-gel
CN114903968A (en) Herbal composition, preparation method and application
Isadkar et al. Aloe vera as denture cleanser
US20040146587A1 (en) Topical composition for relief of pain and minor skin irritations
JPH07278001A (en) External preparation for skin and bathing agent
EP0465313B1 (en) Healing composition for local application
EP0717613B1 (en) Stable composition containing wheat sprout juice and process for producing it
US9867775B2 (en) Topical pharmaceutical bases for treating inflammatory disorders
WO1996009834A1 (en) Treatment of periodontal and acute gingival infections
RU2706333C1 (en) Ointment for wound healing
RU2736218C1 (en) Ointment for treating burns
RU2460513C2 (en) Oil beauty product for care of dry skin
Zuikina et al. Research on the composition development and phyto-ointment technology for complex mastopathy therapy